A U.S.-based company has developed a single-molecule counting technology for use in clinical diagnostics and scientific discovery. The company also provides an ultra-sensitive immunoassay technology platform and laboratory testing services tailored to biomarker validation in the pharmaceutical and biotechnology sectors.
The company had begun selling its flagship product on the US market and was preparing to launch in Europe. Initially, they were uncertain as to where in Europe to locate their resources and where their technology might have the greatest potential.
Novoptim identified a business opportunity for the development of new highly sensitive immuno-assay services by maintaining close contact with the market’s major players. This resulted in an expansion of the client’s product portfolio and the creation of new revenue streams.
This Sales Outsourcing Program generated $1 million in revenue within the first year by converting European early adopters into key customers and installing 3 instruments in top pharmaceutical laboratories. These efforts led to increased market visibility and over $2.5M in revenue within 2 years.
Whether you’re entering the market or scaling your presence, we’re here to turn your innovation into commercial success.